Population genetic study of the brain-derived neurotrophic factor (BDNF) gene
- PMID: 19255578
- PMCID: PMC2888876
- DOI: 10.1038/mp.2009.24
Population genetic study of the brain-derived neurotrophic factor (BDNF) gene
Abstract
Genetic variants in the brain-derived neurotrophic factor (BDNF) gene, predominantly the functional Val66Met polymorphism, have been associated with risk of bipolar disorder and other psychiatric disorders. However, not all studies support these findings, and overall the evidence for the association of BDNF with disease risk is weak. As differences in population genetic structure between patient samples could cause discrepant or spurious association results, we investigated this possibility by carrying out population genetic analyses of the BDNF genomic region. Substantial variation was detected in BDNF coding region single-nucleotide polymorphism (SNP) allele and haplotype frequencies between 58 global populations, with the derived Met allele of Val66Met ranging in frequency from 0 to 72% across populations. F(ST) analyses to assess diversity in the HapMap populations determined that the Val66Met F(ST) value was at the 99.8th percentile among all SNPs in the genome. As the BDNF population genetic differences may be due to local selection, we performed the long-range haplotype test for selection using 68 SNPs spanning the BDNF genomic region in 12 European-derived pedigrees. Evidence for positive selection was found for a high-frequency Val-carrying haplotype, with a relative extended haplotype homozygosity value above the 99 th percentile compared with HapMap data (P=4.6 x 10(-4)). In conclusion, we observed considerable BDNF allele and haplotype diversity among global populations and evidence for positive selection at the BDNF locus. These phenomena can have a profound impact on the detection of disease susceptibility genes and must be considered in gene association studies of BDNF.
Figures


Similar articles
-
BDNF gene is a risk factor for schizophrenia in a Scottish population.Mol Psychiatry. 2005 Feb;10(2):208-12. doi: 10.1038/sj.mp.4001575. Mol Psychiatry. 2005. PMID: 15630410 Clinical Trial.
-
The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:99-104. doi: 10.1016/j.pnpbp.2014.01.012. Epub 2014 Jan 25. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24468644 Free PMC article.
-
BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis.Schizophr Res. 2009 Jul;112(1-3):72-9. doi: 10.1016/j.schres.2009.03.040. Epub 2009 Apr 29. Schizophr Res. 2009. PMID: 19406621
-
BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.Schizophr Res. 2014 Feb;152(2-3):365-72. doi: 10.1016/j.schres.2013.12.011. Epub 2014 Jan 7. Schizophr Res. 2014. PMID: 24411528 Free PMC article.
-
Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis.BMC Psychiatry. 2014 Dec 24;14:366. doi: 10.1186/s12888-014-0366-9. BMC Psychiatry. 2014. PMID: 25539739 Free PMC article. Review.
Cited by
-
Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.Int J Mol Sci. 2020 Oct 21;21(20):7777. doi: 10.3390/ijms21207777. Int J Mol Sci. 2020. PMID: 33096634 Free PMC article. Review.
-
APOE4, Age & Sex Regulate Respiratory Plasticity Elicited By Acute Intermittent Hypercapnic-Hypoxia.bioRxiv [Preprint]. 2023 Jan 7:2023.01.06.522840. doi: 10.1101/2023.01.06.522840. bioRxiv. 2023. Update in: Function (Oxf). 2023 Jun 13;4(5):zqad026. doi: 10.1093/function/zqad026. PMID: 36711653 Free PMC article. Updated. Preprint.
-
The BDNF Val66Met Polymorphism Modulates Resilience of Neurological Functioning to Brain Ageing and Dementia: A Narrative Review.Brain Sci. 2020 Mar 25;10(4):195. doi: 10.3390/brainsci10040195. Brain Sci. 2020. PMID: 32218234 Free PMC article. Review.
-
A sexually dimorphic pre-stressed translational signature in CA3 pyramidal neurons of BDNF Val66Met mice.Nat Commun. 2017 Oct 9;8(1):808. doi: 10.1038/s41467-017-01014-4. Nat Commun. 2017. PMID: 28993643 Free PMC article.
-
New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism.Int J Mol Sci. 2022 Jul 20;23(14):8011. doi: 10.3390/ijms23148011. Int J Mol Sci. 2022. PMID: 35887357 Free PMC article. Review.
References
-
- Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005 Aug;6(8):603–614. - PubMed
-
- Lipsky RH, Marini AM. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Annals of the New York Academy of Sciences. 2007 Dec;1122:130–143. - PubMed
-
- Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci. 2004 May 5;24(18):4401–4411. - PMC - PubMed
-
- Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003 Jan 24;112(2):257–269. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous